TickerFactsScreenerDevelopers

ANAPTYSBIO, INC (ANAB) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2016: $51.23M2017: $81.19M2018: $113.60M2019: $171.02M2020: $250.46M2021: $495.73M2022: $71.31M2023: $35.97M2024: $123.08M2025: $238.20M$238.20M
2016Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$238.20M+93.5%
2024$123.08M+242.2%
2023$35.97M-49.6%
2022$71.31M-85.6%
2021$495.73M+97.9%
2020$250.46M+46.5%
2019$171.02M+50.5%
2018$113.60M+39.9%
2017$81.19M+58.5%
2016$51.23M—